| Literature DB >> 32112966 |
Fabrizio Albarello1, Elisa Pianura1, Federica Di Stefano1, Massimo Cristofaro1, Ada Petrone1, Luisa Marchioni1, Claudia Palazzolo1, Vincenzo Schininà2, Emanuele Nicastri1, Nicola Petrosillo1, Paolo Campioni1, Petersen Eskild3, Alimuddin Zumla4, Giuseppe Ippolito1.
Abstract
INTRODUCTION: Several recent case reports have described common early chest imaging findings of lung pathology caused by 2019 novel Coronavirus (SARS-COV2) which appear to be similar to those seen previously in SARS-CoV and MERS-CoV infected patients.Entities:
Keywords: COVID-19; CT-scan; Crazy-paving; Enlarged pulmonary vessels; Ground glass opacities; SARS-COV2
Mesh:
Year: 2020 PMID: 32112966 PMCID: PMC7110436 DOI: 10.1016/j.ijid.2020.02.043
Source DB: PubMed Journal: Int J Infect Dis ISSN: 1201-9712 Impact factor: 3.623
Figure 1a,b,c. (a, b) Lung VCAR imaging displaying baseline CT and follow-up CT with progressive impairment of the lung parenchyma. (c) lung sparing analysis.
Figure 2a,b. (a) Baseline chest CT images in a 66 years old man displaying multiple patchy ground glass opacities with reticular and interlobular septal thickening: crazy paving. The lesions are mostly distributed in the upper segment of right lower lobe and focal ground glass opacities in the superior segment of left inferior lobe. (b) Mediastinal lymphadenopathies the biggest with short axis of 12 mm.
Figure 3a,b. (a) Follow-up CT in a 66 years old man after 5 days, shows severe progression of pneumonia with increased of extension of ground glass opacities and consolidation. (b) Appearance of bilateral pleural effusion.
Figure 4a,b. (a) Baseline CT images in a 65 years old woman shows patchy ground-glass opacities in the posterior segment of upper right lobe, with pleural contact.(b) Mediastinal lymphadenopathy with short axis of 10 mm.
Figure 5a,b. (a) Follow-up CT after 3 days in a 65 years old woman shows increase size and density of the lesions (b) with bilateral pleural effusion.
Figure 6a,b. (a) Baseline chest CT shows tubular size increase of segmental vessel with normally ventilated adjacent lung parenchyma, (b) where after 3 days there is a ground-glass opacities.
Findings of Chest CT Patient 1 (age 67, gender M).
| CT Findings | First CT | CT after 3 days | CT after 6 days |
|---|---|---|---|
| GGO and consolidation | |||
| GGO | Y | Y | Y |
| Crazy paving | Y | Y | N |
| Consolidation | N | Y | Y |
| GGO + consolidation | N | Y | Y |
| Localization | |||
| Right Upper Lobe | |||
| Apical | Y | Y | Y |
| Posterior | Y | Y | Y |
| Anterior | Y | Y | Y |
| Middle Lobe | |||
| Lateral | Y | Y | Y |
| Medial | N | Y | Y |
| Right Lower Lobe | |||
| Superior | Y | Y | Y |
| Medial | N | Y | Y |
| Anterior | N | N | Y |
| Lateral | N | Y | Y |
| Posterior | Y | Y | Y |
| Left Upper Lobe | |||
| Apical-Posterior | N | Y | Y |
| Anterior | N | Y | Y |
| Lingula | N | Y | Y |
| Left Lower Lobe | |||
| Superior | Y | Y | Y |
| Medial | N | Y | Y |
| Anterior | N | N | Y |
| Lateral | N | Y | Y |
| Posterior | Y | Y | Y |
| >2 lobes affected | Y | Y | Y |
| Bilateral lung disease | Y | Y | Y |
| Pleural impairment | Y | Y | Y |
| Calcifications | N | N | N |
| Tracheal diameter (mm) | 18 × 17 | 18 × 18 | 22 × 19 |
| I–V increase (%) | – | 5% | 10% |
| Pleural effusion (mm) | N | Y | y |
| Lymphadenopathy | 2R/4R/4L | 2R/4R/4L | 2R/4R/4L |
| CPA trunk diameter (mm) | 25 | 25 | 25 |
| Pericardial effusion | N | N | Y |
GGO: Ground Glass Opacity; I–V: Intralesional Vessels.
Findings of Chest CT patient 2 (age 65, gender F).
| CT Findings | First CT | CT after 3 days | CT after 6 days |
|---|---|---|---|
| GGO and consolidation | |||
| GGO | Y | Y | Y |
| Crazy paving | Y | Y | N |
| Consolidation | N | Y | Y |
| GGO + Consolidation | N | Y | Y |
| Localization | |||
| Right Upper Lobe | |||
| Apical | N | Y | Y |
| Posterior | Y | Y | Y |
| Anterior | Y | Y | Y |
| Middle Lobe | |||
| Lateral | N | N | N |
| Medial | Y | Y | Y |
| Right Lower Lobe | |||
| Superior | Y | Y | Y |
| Medial | Y | Y | Y |
| Anterior | N | N | N |
| Lateral | N | N | N |
| Posterior | Y | Y | Y |
| Left Upper Lobe | |||
| Apical-Posterior | Y | Y | Y |
| Anterior | Y | Y | Y |
| Lingula | Y | Y | Y |
| Left Lower Lobe | |||
| Superior | Y | Y | Y |
| Medial | N | Y | Y |
| Anterior | N | N | N |
| Lateral | Y | Y | Y |
| Posterior | Y | Y | Y |
| >2 lobes affected | Y | Y | Y |
| Bilateral lung disease | Y | Y | Y |
| Pleural impairment | Y | Y | Y |
| Calcifications (Nodules) | Y | Y | Y |
| Tracheal diameter (mm) | 13 × 13 | 13 × 13 | 13 × 13 |
| I–V vessels (%) | – | 14 | 5 |
| Pleural effusion | N | N | N |
| Lymphadenopathy | 1/6/10R calcific | 1/6/10R calcific | 1/6/10 Rcalcific |
| CPA trunk diameter (mm) | 28 | 30 | 30 |
| Pericardial effusion | N | N | N |
GGO: Ground Glass Opacity; I–V: Intralesional Vessels; CPA: Common Pulmonary Artery.